Welcome to LookChem.com Sign In|Join Free
  • or
3-Butenoic acid, 3-methyl-2-oxo-4-phenyl-, (E)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

38449-14-8

Post Buying Request

38449-14-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

38449-14-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 38449-14-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,4,4 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 38449-14:
(7*3)+(6*8)+(5*4)+(4*4)+(3*9)+(2*1)+(1*4)=138
138 % 10 = 8
So 38449-14-8 is a valid CAS Registry Number.

38449-14-8Relevant academic research and scientific papers

Polyfunctional (R)-2-Hydroxycarboxylic Acids by Reduction of 2-Oxo Acids with Hydrogen Gas or Formate and Resting Cells of Proteus vulgaris

Schummer, Anita,Yu, Hongtao,Simon, Helmut

, p. 9019 - 9034 (1991)

Various (R)-2-hydroxy acids such as (R)-2-hydroxy-3-enoic-, 3,5-dienoic-, 4-oxo-, (R,S)-3-hydroxy and some others were prepared on a scale up to 0.12 mol by biocatalytic reduction of the corresponding 2-oxo acids with P. vulgaris and hydrogen gas and/or formate as electron donors.With the exception of the 2-hydroxy-4-oxo acids it could be proved that the enantiomeric excess is >97 percent.For the 4-oxo derivatives this enantiomeric excess can be assumed.The yields of isolated products are high because they were isolated from rather small amounts of biocatalyst and low buffer concentrations.Product concentrations in the range of 0.1- 0.24 M were obtained.For 1 mmol of product formation in 15-20 h about 20-40 mg (dry weight) of P. vulgaris cells are necessary.

Active substance combination for the treatment of diabetes

-

Page/Page column 169; 171, (2008/12/07)

The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one drug, used to treat diabetes, a medicament comprising said active substance combination, a pharmaceutical formulation

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 38449-14-8